BC
ELEV

Boxer Capital’s Elevation Oncology ELEV Stock Holding History

Boxer Capital’s Portfolio ELEV Stock Details ELEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-872,780
Closed -$1.22M – 76
2022
Q2 		$1.22M Hold
872,780
– – 0.08% 71
2022
Q1 		$2.2M Hold
872,780
– – 0.11% 65
2021
Q4 		$5.25M Sell
872,780
-468,750
-35% -$3.24M 0.2% 55
2021
Q3 		$10.5M Hold
1,341,530
– – 0.37% 60
2021
Q2 		$18.2M Buy
+1,341,530
New +$16.6M 0.64% 51

Other funds holding ELEV

ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Boxer Capital's ELEV Position: Q3 2022 in Review

Boxer Capital sold out of Elevation Oncology (ELEV) in Q3 2022, closing a stake of 872,780 shares — an estimated $1.22M sold.

Boxer Capital first reported a position in ELEV in Q2 2021 and held it in 5 quarters. The position peaked at $18.2M in Q2 2021. 25 funds tracked by Wall St. Rank hold ELEV as of Q3 2022.

  • Boxer Capital reported no remaining Elevation Oncology position as of Q3 2022 after selling out during the quarter.
  • Boxer Capital sold 872,780 Elevation Oncology shares in Q3 2022, an estimated $1.22M.
  • Boxer Capital first reported a position in Elevation Oncology in Q2 2021 and held it in 5 quarters.
  • Boxer Capital's Elevation Oncology position peaked at $18.2M in Q2 2021.
  • 25 funds tracked by Wall St. Rank held Elevation Oncology as of Q3 2022.

Based on Boxer Capital's 13F filing for Q3 2022, filed 14 Nov 2022.